Optimal Timing of Bisphosphonate Administration in Combination with Samarium-153 Oxabifore in the Treatment of Painful Metastatic Bone Disease

While bisphosphonates are indicated for prevention of skeletal-related events, radionuclide therapy is widely used for treatment of painful bone metastases. Combined radionuclide therapy with bisphosphonates has demonstrated improved effectiveness in achieving bone pain palliation in comparison to m...

Descripción completa

Detalles Bibliográficos
Autores principales: Rasulova, Nigora, Lyubshin, Vladimir, Arybzhanov, Dauranbek, Sagdullaev, Sh., Krylov, Valery, Khodjibekov, Marat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3745627/
https://www.ncbi.nlm.nih.gov/pubmed/23961250
http://dx.doi.org/10.4103/1450-1147.113939

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3745627/
https://www.ncbi.nlm.nih.gov/pubmed/23961250
http://dx.doi.org/10.4103/1450-1147.113939

Ejemplares similares